Icarus Health Care Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 08-12-2024
- Paid Up Capital ₹ 1.00 Cr
as on 08-12-2024
- Company Age 19 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 9.54 Cr
as on 08-12-2024
- Revenue 42.53%
(FY 2022)
- Profit 181.29%
(FY 2022)
- Ebitda 37.02%
(FY 2022)
- Net Worth 0.92%
(FY 2022)
- Total Assets 10.25%
(FY 2022)
About Icarus Health Care
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 1.00 Cr.
The company has closed loans amounting to ₹9.54 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Thangasamy Devaki, Manickam Muthuraman, Muthuraman Alagammai, and Five other members serve as directors at the Company.
- CIN/LLPIN
U24231TN2005PTC055571
- Company No.
055571
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
04 Mar 2005
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Chennai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Icarus Health Care?
Board Members(8)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Thangasamy Devaki  | Director | 04-Mar-2005 | Current |
| Manickam Muthuraman | Director | 04-Mar-2005 | Current |
| Muthuraman Alagammai | Director | 04-Mar-2005 | Current |
| Maruthai Subramani | Director | 04-Mar-2005 | Current |
| Saravanan | Director | 04-Mar-2005 | Current |
| Gurusamy Anandaselvam | Director | 04-Mar-2005 | Current |
Financial Performance of Icarus Health Care.
Icarus Health Care Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 42.53% increase. The company also saw a substantial improvement in profitability, with a 181.29% increase in profit. The company's net worth moved up by a moderate rise of 0.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Icarus Health Care?
In 2022, Icarus Health Care had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Hongkong And Shanghai Banking Corporation Limited Creation Date: 01 Oct 2015 | ₹4.00 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 28 Apr 2014 | ₹3.00 Cr | Satisfied |
Indian Overseas Bank Creation Date: 23 Jul 2009 | ₹2.25 Cr | Satisfied |
How Many Employees Work at Icarus Health Care?
Icarus Health Care has a workforce of 251 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Icarus Health Care, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Icarus Health Care's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
